Dossier
Ovid Therapeutics
Coverage of Ovid Therapeutics in the Nexus archive.
- STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk
Jeremy Levin, founder of Ovid Therapeutics and former CEO of Teva Pharmaceuticals, argues in his book that political upheaval, weakening institutions, and short-term investing threaten the biotech industry's future despite scientific advancements. He advocates for federal policy changes to support biotech investment and for pharmaceutical companies to address regulatory challenges.